Immunoprophylaxis against and prevention of recurrent viral hepatitis after liver transplantation

被引：25

作者：

Laryea, Marie A. ^{[2
]}

Watt, Kymberly D. ^{[1
]}

机构：

[1] Mayo Clin & Mayo Fdn, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA

[2] Dalhousie Univ, Multiorgan Transplant Program, Halifax, NS, Canada

来源：

LIVER TRANSPLANTATION | 2012年 / 18卷 / 05期

关键词：

B IMMUNE GLOBULIN; HBV-RELATED CIRRHOSIS; TERM-FOLLOW-UP; VIRUS RECURRENCE; ADEFOVIR DIPIVOXIL; SURFACE-ANTIGEN; POSITIVE GRAFTS; LOW-RISK; LAMIVUDINE; PROPHYLAXIS;

D O I：

10.1002/lt.23408

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

The reinfection of the hepatic allograft with hepatitis B virus and hepatitis C virus can have important sequelae that result in poor long-term patient and graft survival. Although a response to treatment with antiviral medications can improve these outcomes, not all patients tolerate these medications or experience viral eradication. Avoiding reinfection of the graft is the most effective means of improving the long-term outcomes for these patient populations. This review is focused on the prevention of viral hepatitis reinfection after liver transplantation. Liver Transpl, 2012. (C) 2012 AASLD.

引用

页码：514 / 523

页数：10

共 62 条

[21] Characterization of hepatitis B virus surface antigen and polymerase mutations in liver transplant recipients pre- and post-transplant [J].

Germer, JJ ;

Charlton, MR ;

Ishitani, MB ;

Forehand, CD ;

Patel, R .

AMERICAN JOURNAL OF TRANSPLANTATION, 2003, 3 (06) :743-753

[22] An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy [J].

Han, SHB ;

Ofman, J ;

Holt, C ;

King, K ;

Kunder, G ;

Chen, P ;

Dawson, S ;

Goldstein, L ;

Yersiz, H ;

Farmer, DG ;

Ghobrial, RM ;

Busuttil, RW ;

Martin, P .

LIVER TRANSPLANTATION, 2000, 6 (06) :741-748

[23] Prospects for prophylactic and therapeutic vaccines against the hepatitis C viruses [J].

Houghton, Michael .

IMMUNOLOGICAL REVIEWS, 2011, 239 :99-108

[24] Presence of intrahepatic (Total and ccc) HBV DNA is not predictive of HBV recurrence after liver transplantation [J].

Hussain, Munira ;

Soldevila-Pico, Consuelo ;

Emre, Sukru ;

Luketic, Velimir ;

Lok, Anna S. F. .

LIVER TRANSPLANTATION, 2007, 13 (08) :1137-1144

[25] Posttransplantation Prophylaxis With Primary High-Dose Hepatitis B Immunoglobulin Monotherapy and Complementary Preemptive Antiviral Add-On [J].

Hwang, Shin ;

Ahn, Chul-Soo ;

Song, Gi-Won ;

Kim, Ki-Hun ;

Moon, Deok-Bog ;

Oh, Heung-Bum ;

Lim, Young-Suk ;

Lee, Han Chu ;

Ha, Tae-Yong ;

Jung, Dong-Hwan ;

Chung, Young-Hwa ;

Lee, Sung-Gyu .

LIVER TRANSPLANTATION, 2011, 17 (04) :456-465

[26]

Iacob S, 2008, J GASTROINTEST LIVER, V17, P383

[27] Different effect of HBV vaccine after liver transplantation between chronic HBV carriers and non-HBV patients who received HBcAb-positive grafts [J].

Ishigami, Masatoshi ;

Kamei, Hideya ;

Nakamura, Taro ;

Katano, Yoshiaki ;

Ando, Hisami ;

Kiuchi, Tetsuya ;

Goto, Hidemi .

JOURNAL OF GASTROENTEROLOGY, 2011, 46 (03) :367-377

[28] Current therapeutic strategies for recurrent hepatitis B virus infection after liver transplantation [J].

Jiang, Li ;

Yan, Lu-Nan .

WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (20) :2468-2475

[29] Efficacy and Safety of Entecavir and/or Tenofovir for Prophylaxis and Treatment of Hepatitis B Recurrence Post-Liver Transplant [J].

Jimenez-Perez, M. ;

Saez-Gomez, A. B. ;

Mongil Poce, L. ;

Lozano-Rey, J. M. ;

de la Cruz-Lombardo, J. ;

Rodrigo-Lopez, J. M. .

TRANSPLANTATION PROCEEDINGS, 2010, 42 (08) :3167-3168

[30] Impact of anti-hepatitis Bc-positive grafts on the outcome of liver transplantation for HBV-related cirrhosis [J].

Joya-Vazquez, PP ;

Dodson, FS ;

Dvorchik, I ;

Gray, E ;

Chesky, A ;

Demetris, AJ ;

Shakil, O ;

Fung, JJ ;

Vargas, HE .

TRANSPLANTATION, 2002, 73 (10) :1598-1602

← 1 2 3 4 5 6 7 →